| Stage | HIPO | % of rev | BRK-B | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $156M | 100.00% | $102B | 100.00% | BRK-B ×652.62 |
| Gross profit | $44M | 28.21% | $55.9B | 54.87% | BRK-B +26.7pp |
| Operating income | $9M | 5.71% | $17.1B | 16.77% | BRK-B +11.1pp |
| Pre-tax income | $9M | 5.71% | $31.8B | 31.25% | BRK-B +25.5pp |
| Net income | $9M | 5.64% | $25.8B | 25.31% | BRK-B +19.7pp |
| Stage | HIPO | BRK-B | Gap · A − B |
|---|---|---|---|
| Revenue | $156M100.00% | $102B100.00% | BRK-B ×652.62 |
| Gross profit | 28.21%$44M | 54.87%$55.9B | BRK-B +26.7pp |
| Operating income | 5.71%$9M | 16.77%$17.1B | BRK-B +11.1pp |
| Pre-tax income | 5.71%$9M | 31.25%$31.8B | BRK-B +25.5pp |
| Net income |
| 5.64%$9M |
| 25.31%$25.8B |
| BRK-B +19.7pp |
No disclosed counterparties: HIPO, BRK-B.